Healthcare • Biotechnology
EODHD (TTM) · as of Oct 13, 2026
End-of-day close from stored market data, not a live quote.
Sign in to see your position size
We’ll show you if KARD is in your portfolio and how much it contributes.
Sign inLoading market dates
No upcoming ex-dividend date announced
No 8-K filings in the last 30 days.
23 top institutions tracked
Sentiment: unknown
No recent insider trades detected.
Red flags: 1
69 filers reported a long position in KARD for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
| Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|
| HRTG GPE, LLC | $403.5M | 16.9M | New |
| FMR LLC | $212.5M | 8.9M | New |
| PERCEPTIVE ADVISORS LLC | $195.6M | 8.2M | New |
| T. Rowe Price Investment Management, Inc. | $100.3M | 4.2M | New |
| Capital Research Global Investors | $85.8M | 3.6M | New |
| JPMORGAN CHASE & CO | $46.4M | 1.8M | New |
| ALLIANCEBERNSTEIN L.P. | $36.6M | 1.5M | New |
| Liberty Mutual Group Asset Management Inc. | $28.5M | 1.2M | New |
| JENNISON ASSOCIATES LLC | $21.6M | 903.6K | New |
| Paradigm Biocapital Advisors LP | $21.5M | 900K | New |
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.